Alkem Laboratories Ratios

Alkem Laboratories Ltd Ratios

The Alkem Laboratories Ltd Ratios page provides a complete fundamental analysis of Alkem Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Alkem Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Alkem Laboratories Ltd (NSE: ALKEM, BSE: 539523) is currently trading at ₹5402.50, with a market capitalization of ₹700.45B. As a major player in the Health technology sector and Pharmaceuticals: major industry, Alkem Laboratories Ltd remains a key stock for fundamental analysis using Alkem Laboratories Ltd Ratios.

Alkem Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Alkem Laboratories Ltd P/E ratio currently stands at 26.94, making it one of the most tracked metrics in Alkem Laboratories Ltd Ratios.

Historically, the Alkem Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 26.94
• 2023: 32.89
• 2022: 41.28
• 2021: 26.28
• 2020: 20.91

The decline in Alkem Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Alkem Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 4.87.

Historical P/B trend:

• 2024: 4.87
• 2023: 5.73
• 2022: 4.49
• 2021: 5.01

Alkem Laboratories Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Alkem Laboratories Ltd P/S ratio currently stands at 4.51, an important part of Alkem Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 4.51
• 2023: 4.70
• 2022: 3.51
• 2021: 4.07

A stable or declining Alkem Laboratories Ltd P/S ratio indicates cautious market sentiment.

Alkem Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The Alkem Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 26.76.

Historical Alkem Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 26.76
• 2023: 28.18
• 2022: 23.36
• 2021: 37
• 2020: 25.70

The declining Alkem Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Alkem Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Alkem Laboratories Ltd EV currently stands at ₹556.76B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 556.76B
• 2023: 563.98B
• 2022: 394.79B
• 2021: 434.08B

Alkem Laboratories Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Alkem Laboratories Ltd EV/EBITDA ratio is currently 21.90, a key metric in Alkem Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 21.90
• 2023: 25.06
• 2022: 23.54
• 2021: 20.79

Stable Alkem Laboratories Ltd EV/EBITDA indicates balanced valuation.

Alkem Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Alkem Laboratories Ltd D/E ratio is currently 0.12, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.12
• 2023: 0.14
• 2022: 0.15
• 2021: 0.31

Alkem Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Alkem Laboratories Ltd ROE currently stands at 19.42%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 19.42
• 2023: 18.55
• 2022: 11.13
• 2021: 20.55

Alkem Laboratories Ltd maintains stable profitability levels.

Alkem Laboratories Ltd Ratios Analysis Summary

The Alkem Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Alkem Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Alkem Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.